Resultado da Busca
15 de jul. de 2016 · Of all patients with metastatic cancer, the most common sites of metastasis were the liver (70% in colon cancer/70% in rectal cancer) and the thorax (32%/47%). In colon cancer, the third most common site was the peritoneum (21%) whereas in rectal cancer it was the bone (12%).
- Diagnosis and Treatment of Metastatic Colorectal Cancer: A ...
Abstract. Importance: Colorectal cancer (CRC) is the third...
- Diagnosis and Treatment of Metastatic Colorectal Cancer: A ...
17 de out. de 2022 · PDF. Abstract. Purpose. To develop recommendations for treatment of patients with metastatic colorectal cancer (mCRC). Methods. ASCO convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. Results.
25 de out. de 2022 · Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomised trials.
Há 4 dias · Despite extensive research and improvements in understanding colorectal cancer (CRC), its metastatic form continues to pose a substantial challenge, primarily owing to limited therapeutic options ...
25 de out. de 2022 · disease will develop metastases. The most common location of metastases being liver, then lung, peritoneum and distant lymph nodes.
Metastatic CRC may consist of tumors identified at a distant site following a previously treated localized CRC (nonmetastatic or stage I-III) or may present de novo at stage IV, defined as metastatic disease or cancer that has spread outside the original colorectal mass.
16 de fev. de 2021 · Abstract. Importance: Colorectal cancer (CRC) is the third most common cause of cancer mortality worldwide with more than 1.85 million cases and 850 000 deaths annually. Of new colorectal cancer diagnoses, 20% of patients have metastatic disease at presentation and another 25% who present with localized disease will later develop metastases.
